Global Market Sees More Growth

November 2010
Pharmaceutical Representative;Nov2010, Vol. 40 Issue 11, p9
The article reports on the forecast released by IMS Health Inc. which revealed that the value of the global pharmaceutical market is expected to increase to 880 billion dollars in 2011.


Related Articles

  • Focus shifts to replenishing pipeline.  // Drug Store News;8/18/2008, Vol. 30 Issue 9, p95 

    The article features an economic forecast of leading drug companies in the U.S. According to IMS Health, drugs with $20 billion worth of annual sales are expected to lose patent protection in 2008, thus putting an enormous pressure on the industry with a flood of generics. Analysts believed that...

  • IMS Study Says Drugs Will Maintain Growth.  // Chemical Market Reporter;09/27/99, Vol. 256 Issue 13, p24 

    Focuses on IMS Health study on pharmaceutical retail sales. Sales increased for the 12 key global markets during the 12 month period from August 1998 to July 1999; Growth of the United States retail sales during the period; Total sales for Germany, France, Italy, Great Britain and Spain; Sales...

  • Squeeze on Pharma. Wechsler, Jill // Pharmaceutical Executive;Dec2008, Vol. 28 Issue 12, p16 

    The article predicts the pharmaceutical industry's development. According to IMS Health Inc., the U.S. drug sales will rise only 1-2 percent next year, with sales hovering around $300 billion. Meanwhile, rising unemployment and economic uncertainty may curb patient visits to doctors. It also...

  • MEXICO.  // Pharmaceutical Executive;Dec2016, Vol. 36 Issue 12, pS2 

    The article focuses on healthcare and life sciences industry in Mexico. Topics discussed include pharmaceutical industry became critical sector for Mexico's economy, growth in pharmaceutical market in Mexico for 2014-2015 as per Information technology IMS Health, and views of José Narro...

  • A new landscape for drugs: IMS data point to pharmaceuticals in flux. Doran, Ryan // Fairfield County Business Journal;1/12/2009, Vol. 48 Issue 2, p5 

    The article reports on the decline in prescription drug-spending in the U.S. as described in the report authored by Murray Aitken, of IMS Health of Norwalk and economist Ernst Berndt. According to to the report prescription drug spending in 2007 reached a 30 year low due to increased use of...

  • TOP STORIES.  // MondayMorning;3/17/2008, Vol. 16 Issue 11, p1 

    This article states that drug sales in the U.S. grew at their slowest pace since 1961 as cheaper copies of top-selling medicines flooded the market and U.S. regulators approved fewer new products. According to health research firm IMS Health Inc. sales of medicines rose 3.8% to $286.5 billion in...

  • Big pharma's edge in biogenencs. Challener, Cynthia // ICIS Chemical Business;2/15/2010, Vol. 277 Issue 6, p28 

    The article presents information on the growing popularity of biologic drugs. It is stated that products, derived from biological processes, present unusual challenges to generics firms. It has been predicted that sales of biologies will increase to 202 billion dollars by 2013. U.S.-based...

  • Shifting Fortunes in API Market Growth. Van Arnum, Patricia // Pharmaceutical Technology;Aug2009, Vol. 33 Issue 8, p38 

    The article provides an overview on the market sales of pharmaceutical products in the U.S. A study conducted by IMS Health Inc. suggests that the global market for prescription drugs has increased by 4.8% in 2008. A key reason for the slow growth in the global pharmaceutical market was a slight...

  • Market Watch: JAPAN.  // Pharmaceutical Technology;May2008, Vol. 32 Issue 5, p26 

    The article reports that the sales of pharmaceutical drug in Japan is expected to grow in 2008 as the latest figures from IMS Health Inc. It has been reported that despite the lower forecast, Japan is still the largest market in the Asia-Pacific region and second largest individual market in the...


Read the Article


Sign out of this library

Other Topics